Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Travera Inc
AstraZeneca
Institut Bergonié
University of Pittsburgh
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Shanghai Escugen Biotechnology Co., Ltd
Sahlgrenska University Hospital
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Incyte Corporation
NGM Biopharmaceuticals, Inc
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
The Christie NHS Foundation Trust
UNC Lineberger Comprehensive Cancer Center
Stanford University
Lindis Bloodcare GmbH
Taproot Health
Acepodia Biotech, Inc.
UNC Lineberger Comprehensive Cancer Center
DxTerity Diagnostics
Xencor, Inc.
Arcus Biosciences, Inc.
Cedars-Sinai Medical Center
STCube, Inc.
Corvus Pharmaceuticals, Inc.
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
Klus Pharma Inc.
Revolution Medicines, Inc.
Quadriga Biosciences, Inc.
University Health Network, Toronto
Exact Sciences Corporation
University of Alberta
Augusta University
Pfizer
MacroGenics
Incyte Corporation
Seagen Inc.
EMD Serono
Seagen Inc.
Gilead Sciences
Seagen Inc.
Abramson Cancer Center at Penn Medicine
Celgene